Pyroptosis, inflammasome, and gasdermins in tumor immunity

The gasdermins (GSDM), a family of pore-forming proteins, consist of gasdermin A (GSDMA), gasdermin B (GSDMB), gasdermin C (GSDMC), gasdermin D (GSDMD), gasdermin E (GSDME) and DFNB59 (Pejvakin (PJVK)) in humans. These proteins play an important role in pyroptosis. Among them, GSDMD is the most extensively studied protein and is identified as the executioner of pyroptosis. Other family members have also been implicated in certain cancers. As a unique form of programmed cell death, pyroptosis is closely related to tumor progression, and the inflammasome, an innate immune mechanism that induces inflammation and pyroptosis. In this review, we explore the current developments of pyroptosis, the inflammasome, and especially we review the gasdermin family members and their role in inducing pyroptosis and the possible therapeutic values in antitumor effects.

[1]  Doris L. LaRock,et al.  Group A Streptococcus induces GSDMA-dependent pyroptosis in keratinocytes , 2022, Nature.

[2]  A. Burlingame,et al.  Epithelial STAT6 O-GlcNAcylation drives a concerted anti-helminth alarmin response dependent on tuft cell hyperplasia and Gasdermin C. , 2022, Immunity.

[3]  J. Lieberman,et al.  Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis , 2022, Nature.

[4]  J. Lieberman,et al.  NLRP3 inflammasome activation triggers gasdermin D–independent inflammation , 2021, Science Immunology.

[5]  Si Ming Man,et al.  Cell biology of inflammasome activation. , 2021, Trends in cell biology.

[6]  Dawang Zhou,et al.  The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8 , 2021, Cell Research.

[7]  D. Heisler,et al.  Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions , 2021, Cell.

[8]  Feizhou Lyu,et al.  CD73 alleviates GSDMD‐mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling , 2020, Clinical and translational medicine.

[9]  Sky W. Brubaker,et al.  A Rapid Caspase-11 Response Induced by IFNγ Priming Is Independent of Guanylate Binding Proteins , 2020, iScience.

[10]  J. Tainer,et al.  PD-L1-Mediated Gasdermin C Expression Switches Apoptosis to Pyroptosis in Cancer Cells and Facilitates Tumor Necrosis , 2020, Nature Cell Biology.

[11]  Xianjun Yu,et al.  Ferroptosis, necroptosis, and pyroptosis in anticancer immunity , 2020, Journal of Hematology & Oncology.

[12]  Xiaoyan Chen,et al.  Induction of ASC pyroptosis requires gasdermin D or caspase-1/11-dependent mediators and IFNβ from pyroptotic macrophages , 2020, Cell Death & Disease.

[13]  J. Qu,et al.  Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy. , 2020, Biomaterials.

[14]  L. Shen,et al.  Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells , 2020, Science.

[15]  Kailiang Zhou,et al.  Role of pyroptosis in liver diseases. , 2020, International immunopharmacology.

[16]  Huanwei Huang,et al.  A bioorthogonal system reveals antitumour immune function of pyroptosis , 2020, Nature.

[17]  R. Jain,et al.  Combining microenvironment normalization strategies to improve cancer immunotherapy , 2020, Proceedings of the National Academy of Sciences.

[18]  J. Lieberman,et al.  Gasdermin E suppresses tumor growth by activating anti-tumor immunity , 2020, Nature.

[19]  Xiao-hui Zhang,et al.  Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome , 2020, Science Immunology.

[20]  Ping Liu,et al.  Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway , 2020, BMC Cancer.

[21]  Hao Wu,et al.  Mechanism and Regulation of Gasdermin-Mediated Cell Death. , 2019, Cold Spring Harbor perspectives in biology.

[22]  E. Lien,et al.  Gasdermins and their role in immunity and inflammation , 2019, The Journal of experimental medicine.

[23]  J. Claude,et al.  A genome‐wide screen identifies IRF2 as a key regulator of caspase‐4 in human cells , 2019, EMBO reports.

[24]  B. Wan,et al.  GSDMD is required for effector CD8+ T cell responses to lung cancer cells. , 2019, International immunopharmacology.

[25]  Derek W. Abbott,et al.  Crystal Structures of the Full-Length Murine and Human Gasdermin D Reveal Mechanisms of Autoinhibition, Lipid Binding, and Oligomerization. , 2019, Immunity.

[26]  R. Vance,et al.  Gasdermin-D and Caspase-7 are the key Caspase-1/8 substrates downstream of the NAIP5/NLRC4 inflammasome required for restriction of Legionella pneumophila , 2019, PLoS pathogens.

[27]  G. Salvesen,et al.  Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation. , 2019, Cell reports.

[28]  Xiaozheng Xu,et al.  Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis. , 2019, Cancer letters.

[29]  T. Andrews,et al.  IRF2 transcriptionally induces GSDMD expression for pyroptosis , 2019, Science Signaling.

[30]  Kaiwen W. Chen,et al.  Extrinsic and intrinsic apoptosis activate pannexin‐1 to drive NLRP3 inflammasome assembly , 2019, The EMBO journal.

[31]  E. Alnemri,et al.  Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation , 2019, Nature Communications.

[32]  L. Guohua,et al.  Role of pyroptosis in cardiovascular disease , 2018, Cell proliferation.

[33]  G. Shrivastava,et al.  Gasdermin D Restrains Type I Interferon Response to Cytosolic DNA by Disrupting Ionic Homeostasis , 2018, Immunity.

[34]  Si Ming Man,et al.  Mechanisms of Gasdermin Family Members in Inflammasome Signaling and Cell Death. , 2018, Journal of molecular biology.

[35]  K. Schroder,et al.  Noncanonical inflammasome signaling elicits gasdermin D–dependent neutrophil extracellular traps , 2018, Science Immunology.

[36]  Haichao Wang,et al.  Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis. , 2018, Cell host & microbe.

[37]  G. Neale,et al.  IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation , 2018, Cell.

[38]  J. Lieberman,et al.  Cryo-EM structure of the gasdermin A3 membrane pore , 2018, Nature.

[39]  Jedd D. Wolchok,et al.  Cancer immunotherapy using checkpoint blockade , 2018, Science.

[40]  T. Cheng,et al.  Gasdermin D Exerts Anti-inflammatory Effects by Promoting Neutrophil Death , 2018, Cell reports.

[41]  K. Magalhães,et al.  Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells , 2018, Scientific Reports.

[42]  E. Miao,et al.  Gasdermins: Effectors of Pyroptosis. , 2017, Trends in cell biology.

[43]  Wenqing Gao,et al.  Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin , 2017, Nature.

[44]  D. Bachovchin,et al.  Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages. , 2017, Cell chemical biology.

[45]  E. Dueber,et al.  Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions. , 2017, Trends in immunology.

[46]  C. Laprise,et al.  Role of DNA methylation in expression control of the IKZF3-GSDMA region in human epithelial cells , 2017, PloS one.

[47]  A. Liston,et al.  Homeostasis-altering molecular processes as mechanisms of inflammasome activation , 2017, Nature Reviews Immunology.

[48]  E. Miao,et al.  Programmed cell death as a defence against infection , 2017, Nature Reviews Immunology.

[49]  E. Alnemri,et al.  Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death , 2017, Nature Communications.

[50]  L. Zitvogel,et al.  Immunogenic cell death in cancer and infectious disease , 2016, Nature Reviews Immunology.

[51]  H. Ohdan,et al.  Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation , 2016, PloS one.

[52]  B. Krantz,et al.  Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis , 2016, The Journal of experimental medicine.

[53]  H. Stahlberg,et al.  GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death , 2016, The EMBO journal.

[54]  Dacheng Wang,et al.  Pore-forming activity and structural autoinhibition of the gasdermin family , 2016, Nature.

[55]  J. Lieberman,et al.  Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores , 2016, Nature.

[56]  V. Dixit,et al.  Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.

[57]  Jedd D. Wolchok,et al.  PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations , 2016, Science Translational Medicine.

[58]  Z. Yang,et al.  Cancer therapy in the necroptosis era , 2016, Cell Death and Differentiation.

[59]  Si Ming Man,et al.  Converging roles of caspases in inflammasome activation, cell death and innate immunity , 2015, Nature Reviews Immunology.

[60]  Xiaoguang Lei,et al.  Using Small Molecules to Dissect Non‐apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis , 2015, Chembiochem : a European journal of chemical biology.

[61]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[62]  T. Cai,et al.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.

[63]  K. Schroder,et al.  NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5 , 2015, European journal of immunology.

[64]  Liang-Tung Yang,et al.  N-terminal functional domain of Gasdermin A3 regulates mitochondrial homeostasis via mitochondrial targeting , 2015, Journal of Biomedical Science.

[65]  R. Vance,et al.  The NLRP1 inflammasomes , 2015, Immunological reviews.

[66]  P. Li,et al.  Inflammatory caspases are innate immune receptors for intracellular LPS , 2014, Nature.

[67]  R. Flavell,et al.  Detecting “different”: Pyrin senses modified GTPases , 2014, Cell Research.

[68]  D. Ehrnhoefer,et al.  p53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin. , 2014, Human molecular genetics.

[69]  W. Lin,et al.  Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling , 2014, Cell Death and Disease.

[70]  Simon C Watkins,et al.  Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells , 2013, Nature Cell Biology.

[71]  Richard A. Flavell,et al.  Inflammasomes in health and disease , 2012, Nature.

[72]  Jinfeng Liu,et al.  Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.

[73]  K. Ogawa,et al.  Distinctive expression and function of four GSDM family genes (GSDMA‐D) in normal and malignant upper gastrointestinal epithelium , 2009, Genes, chromosomes & cancer.

[74]  G. Superti-Furga,et al.  An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome , 2009, Nature Immunology.

[75]  Craig Murdoch,et al.  The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.

[76]  F. He,et al.  Expression of GSDML Associates with Tumor Progression in Uterine Cervix Cancer. , 2008, Translational oncology.

[77]  R. Schneider-Stock,et al.  Differential expression and localisation of gasdermin‐like (GSDML), a novel member of the cancer‐associated GSDMDC protein family, in neoplastic and non‐neoplastic gastric, hepatic, and colon tissues , 2008, Pathology.

[78]  K. Ogawa,et al.  GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-β-dependent apoptotic signalling , 2007, Oncogene.

[79]  K. Sumiyama,et al.  Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner. , 2007, Genomics.

[80]  M. Toyota,et al.  Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer , 2007, Cancer science.

[81]  M. Ohki,et al.  The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage , 2006, Journal of Human Genetics.

[82]  N. Ben-Tal,et al.  Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy , 2006, Nature Genetics.

[83]  H. Fuchs,et al.  The dominant alopecia phenotypes Bareskin, Rex-denuded, and Reduced Coat 2 are caused by mutations in gasdermin 3. , 2004, Genomics.

[84]  M. Katoh,et al.  Identification and characterization of human CXXC10 gene in silico. , 2004, International journal of oncology.

[85]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[86]  C. Dong,et al.  Gene expression profiling in human fetal liver and identification of tissue- and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs. , 2001, Genome research.

[87]  Y. Matsuzawa,et al.  Structure, Expression and Chromosome Mapping of MLZE, a Novel Gene Which Is Preferentially Expressed in Metastatic Melanoma Cells , 2001, Japanese journal of cancer research : Gann.

[88]  N. Saeki,et al.  Gasdermin (Gsdm) localizing to mouse Chromosome 11 is predominantly expressed in upper gastrointestinal tract but significantly suppressed in human gastric cancer cells , 2000, Mammalian Genome.

[89]  G. Richardson,et al.  Nonsyndromic hearing impairment is associated with a mutation in DFNA5 , 1998, Nature Genetics.

[90]  M. Prevost,et al.  Shigella flexneri induces apoptosis in infected macrophages , 1992, Nature.

[91]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.